MarketCap
Facebook
X
Telegram
Tilray Long Term Debt Current | TLRY
Annual Long Term Debt Current Tilray
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.25 M | 5.38 M | 4 M | 2.42 M | 6.7 M | - | - | 2.47 M | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.25 M | 2.42 M | 4.87 M |
Long Term Debt Current of other stocks in the Drug manufacturers industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aurora Cannabis
ACB
|
5.38 M | $ 5.24 | 0.87 % | $ 287 M |  Canada |
 |
Harrow Health
HROW
|
887 K | $ 26.86 | 3.15 % | $ 987 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
468 K | $ 5.26 | 4.99 % | $ 78.1 M | USA |
 |
Emergent BioSolutions
EBS
|
2.4 M | $ 6.04 | 3.25 % | $ 323 M | USA |
 |
Cronos Group
CRON
|
337 K | $ 3.62 | -2.82 % | $ 1.39 B | Canada |
 |
Evolus
EOLS
|
2.53 M | $ 6.86 | 0.88 % | $ 442 M | USA |
 |
Bausch Health Companies
BHC
|
61 M | $ 8.19 | 2.7 % | $ 3.04 B | Canada |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 0.88 | -5.39 % | $ 83.9 M | Canada |
 |
SCYNEXIS
SCYX
|
483 K | $ 3.51 | 6.21 % | $ 175 M | USA |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
12.5 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Sonoma Pharmaceuticals
SNOA
|
151 K | $ 1.12 | 5.1 % | $ 1.89 M | USA |
 |
TherapeuticsMD
TXMD
|
975 K | $ 1.7 | -0.58 % | $ 19.7 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
100 K | - | 7.5 % | $ 6.35 M | USA |
 |
Assertio Holdings
ASRT
|
240 K | - | - | $ 150 M | USA |
 |
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | Canada |
 |
ProPhase Labs
PRPH
|
1.21 M | - | - | $ 5.07 M | USA |
 |
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | USA |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Organogenesis Holdings
ORGO
|
4.95 M | $ 0.84 | 0.19 % | $ 106 M | USA |
 |
Evoke Pharma
EVOK
|
59.5 K | - | - | $ 36.6 M | USA |
 |
Pacira BioSciences
PCRX
|
9.84 M | $ 36.43 | 0.03 % | $ 1.62 B | USA |
 |
Perrigo Company plc
PRGO
|
25.7 M | $ 15.83 | 0.83 % | $ 2.19 B | USA |
 |
Rockwell Medical
RMTI
|
1.16 M | $ 7.76 | 2.04 % | $ 279 M | USA |
 |
Solid Biosciences
SLDB
|
2.1 M | $ 6.65 | 7.52 % | $ 582 M | USA |
 |
Sundial Growers
SNDL
|
35.5 M | $ 1.42 | 2.54 % | $ 366 M | Canada |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Veru
VERU
|
759 K | $ 2.14 | 3.88 % | $ 31.3 M | USA |
 |
Viatris
VTRS
|
109 M | $ 19.72 | 5.03 % | $ 22.9 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
cbdMD
YCBD
|
778 K | $ 0.42 | 6.96 % | $ 1.69 M | USA |
 |
China Pharma Holdings
CPHI
|
71.6 K | $ 0.57 | 8.66 % | $ 2.45 M |  China |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
DURECT Corporation
DRRX
|
1.08 M | - | - | $ 50.1 M | USA |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
OptiNose
OPTN
|
1.25 M | - | - | $ 1.08 B | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |